Vitamin/Mineral Supplement for Children and Adults With Autism
NCT01225198 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 143
Last updated 2010-10-20
Summary
The investigators hypothesis is that a new, revised formulation of a vitamin/mineral supplement will result in:
1. improvement of nutritional status in some children/adults with autism, and
2. reduction of some of the symptoms of autism in some children
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Multi-Vitamin/Mineral Supplement
A broad-spectrum vitamin/mineral supplement designed for children and adults with autism
- OTHER
-
Liquid Placebo
The placebo was formulated to look and taste like the intervention supplement. A small amount of beta-carotene was used for coloring. Natural cherry, citric acid, and a proprietary blend of natural flavors were used for flavoring to create a vitamin-like after-taste. Sucralose was used as a sweetener and the same preservatives were included (potassium sorbate, sodium benzoate).
Sponsors & Collaborators
-
Autism Research Institute
collaborator UNKNOWN -
Legacy Foundation
collaborator UNKNOWN -
Arizona State University
lead OTHER
Principal Investigators
-
James B. Adams, PhD · Arizona State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism
NCT01039792 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism
NCT00325572 ·Status: TERMINATED ·Phase: PHASE1
-
Therapeutic Issues for Autism
NCT03887754 ·Status: COMPLETED ·Phase: PHASE2
-
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial
NCT05664789 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
NCT00676195 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder
NCT02733120 ·Status: COMPLETED ·Phase: NA
-
Early Nutritional Intervention in Patients With Autism Spectrum Disorders
NCT01230359 ·Status: COMPLETED ·Phase: NA
-
A Study of Glutathione in Children With Autism Spectrum Disorder
NCT05954052 ·Status: TERMINATED ·Phase: PHASE4
-
Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.
NCT04312152 ·Status: UNKNOWN ·Phase: NA
-
A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder
NCT03664232 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
NCT06234501 ·Status: RECRUITING ·Phase: NA
-
Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior
NCT01366859 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
NCT00453180 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Therapeutic Diet With Physiotherapy on Gross Motor and Cognition of Autistic Children
NCT06086964 ·Status: COMPLETED ·Phase: NA
-
Study on the Treatment of Taurine in Children With Autism
NCT05980520 ·Status: COMPLETED ·Phase: NA
-
Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
NCT00773812 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders
NCT00859664 ·Status: UNKNOWN
-
Folinic Acid in Autism
NCT03771560 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Characteristics of Eye Diseases in Children and Adolescents With Autism Spectrum Disorders and the Effect of Corresponding Treatment on the Quality of Life of Children and Adolescents With Autism and Their Caregivers
NCT06122519 ·Status: RECRUITING
-
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
NCT02414451 ·Status: WITHDRAWN ·Phase: NA
-
Combination of Supplements for Treating Autistic Spectrum Disorder
NCT06756711 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label
NCT05494398 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder
NCT04600882 ·Status: WITHDRAWN
-
Parent-Mediated Intervention for Families With Children With Autism and Feeding Challenges, Australia Cohort
NCT05852548 ·Status: COMPLETED ·Phase: NA
-
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
NCT02911194 ·Status: COMPLETED ·Phase: NA